Skip to content

Markers for Determining Atrial Remodeling in Patients with Atrial Fibrillation

Markers for Determining Atrial Remodeling in Patients with Atrial Fibrillation - MARK AF

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON55444
Enrollment
1000
Registered
2014-11-21
Start date
2015-02-19
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation heart rhythm disturbances

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients with AF, undergoing VATS-PVI - Age between 18 and 80 years - Symptomatic AF, paroxysmal, persistent or longstanding persistent - AF was documented on ECG/Holter/Pacemaker electrogram at least once in the 12 months preceding presentation

Exclusion criteria

Exclusion criteria: - Left ventricular ejection fraction

Design outcomes

Primary

MeasureTime frame
Changes in biomarkers involved in the remodelling process of the atrium in AF will be related to the outcome after treatment.

Secondary

MeasureTime frame
NVT

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)